The Yale Center for Immuno-Oncology was established in 2018 to build on Yale Cancer Center’s international leadership in immunology, immunobiology, and the development of innovative cancer immunotherapies. The Center is a partnership between Yale Cancer Center and the Department of Immunobiology at Yale School of Medicine.
The goals for the Yale Center for Immuno-Oncology (YCIO) include to:
Leverage Yale leadership in immunobiology and immunotherapy drug development.
Develop the next generation of immune-based therapies.
Genetically engineer immune cells to target a patient’s cancer (cell therapies).
“This new center gives us the chance to work more collaboratively and efficiently with our world-renowned scientists and faculty to address scientific questions in Immuno-Oncology,” said Marcus Bosenberg, MD, PhD, Professor of Dermatology, Pathology, and Immunobiology, and interim director of YCIO.
Professor of Medicine (Medical Oncology); Interim Associate Cancer Center Director, Diversity, Equity, and Inclusion; Chief, Head and Neck Cancers/Sarcoma; Disease Aligned Research Team Leader, Head and Neck Cancers Program; Co-Leader, Developmental Therapeutics, Yale Cancer Center
Head and Neck Neoplasms
Chemicals and Drugs
Analytical, Diagnostic and Therapeutic Techniques and Equipment
Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology; Director, Center for Thoracic Cancers; Deputy Director, Clinical Affairs; Assistant Dean for Translational Research, Office of the Dean, School of Medicine; Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital; Associate Cancer Center Director, Translational Science
Sterling Professor of Immunobiology and Professor of Dermatology and of Molecular, Cellular, and Developmental Biology and of Epidemiology (Microbial Diseases); Investigator, Howard Hughes Medical Institute
Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; Director, Yale SPORE in Skin Cancer, Yale Cancer Center; Vice Chair for Translational Research, Internal Medicine; Chief, Division of Skin and Kidney Cancer; Associate Cancer Center Director, Education, Training and Faculty Development; Deputy Section Chief, Medical Oncology
Anthony N. Brady Professor of Laboratory Medicine and Professor of Pathology; Vice Chair for Research Affairs, Laboratory Medicine; Assoc. Director, Yale Stem Cell Center; Assoc. Director, Transfusion Medicine Service; Medical Director, Clinical Cell Processing Laboratory; Medical Director, Advanced Cell Therapy Laboratory